Literature DB >> 16124170

Natural history of cervical intraepithelial neoplasia: a meta-analysis.

Scott B Cantor1, E Neely Atkinson, Marylou Cardenas-Turanzas, J L Benedet, Michele Follen, Calum MacAulay.   

Abstract

OBJECTIVE: To determine the probabilities of transition of stages in the cervical cancer by conducting a meta-studies on the topic. STUDY
DESIGN: We identified health states of interest in the natural history of cervical precancer, identified all possible papers that could meet selection criteria, developed relevance and acceptability criteria for inclusion, then thoroughly reviewed the selected studies. To determine the transition probability data we used a random effects model. We determined probabilities for 4 health state transitions. The 6-month mean predictive transition probability (95% confidence intervals with "prediction interval" in parentheses) for high grade squamous intraepithelial lesions (HSIL) to cancer was 0.0037 (0.00004, 0.03386), for low grade squamous intraepithelial lesions (LSIL) to HSIL was 0.0362 (0.00055, 0.23220), for HSIL to LSIL was 0.0282 (0.00027, 0.35782), and for LSIL to normal was 0.0740 (0.00119, 0.42672).
CONCLUSION: The transition probabilities between cervical cancer health states for 6-month intervals are small; however, the cumulative risk of cervical cancer is significant. Markers to identify the cervical precursors that will lead to the transition to cervical cancer are needed.

Entities:  

Mesh:

Year:  2005        PMID: 16124170     DOI: 10.1159/000326174

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  12 in total

1.  Optical technologies and molecular imaging for cervical neoplasia: a program project update.

Authors:  Timon P H Buys; Scott B Cantor; Martial Guillaud; Karen Adler-Storthz; Dennis D Cox; Clement Okolo; Oyedunni Arulogon; Oladimeji Oladepo; Karen Basen-Engquist; Eileen Shinn; José-Miguel Yamal; J Robert Beck; Michael E Scheurer; Dirk van Niekerk; Anais Malpica; Jasenka Matisic; Gregg Staerkel; Edward Neely Atkinson; Luc Bidaut; Pierre Lane; J Lou Benedet; Dianne Miller; Tom Ehlen; Roderick Price; Isaac F Adewole; Calum MacAulay; Michele Follen
Journal:  Gend Med       Date:  2011-09-22

2.  Anal squamous cell carcinoma in the HIV-positive patient.

Authors:  Deborah Nagle
Journal:  Clin Colon Rectal Surg       Date:  2009-05

3.  Physician attitudes toward dissemination of optical spectroscopy devices for cervical cancer control: an industrial-academic collaborative study.

Authors:  Eileen Shinn; Usman Qazi; Shalini Gera; Joan Brodovsky; Jessica Simpson; Michele Follen; Karen Basen-Engquist; Calum Macaulay
Journal:  Gend Med       Date:  2012-02

4.  Characterization of Molecular Markers Indicative of Cervical Cancer Progression.

Authors:  Hilal Arnouk; Mark A Merkley; Robert H Podolsky; Hubert Stöppler; Carlos Santos; Manuel Alvarez; Julio Mariategui; Daron Ferris; Jeffrey R Lee; William S Dynan
Journal:  Proteomics Clin Appl       Date:  2009-05-05       Impact factor: 3.494

5.  Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer.

Authors:  Fang Wan; Xijiang Miao; Iram Quraishi; Valerie Kennedy; Kim E Creek; Lucia Pirisi
Journal:  Int J Cancer       Date:  2008-07-01       Impact factor: 7.396

6.  Stratification of HPV-induced cervical pathology using the virally encoded molecular marker E4 in combination with p16 or MCM.

Authors:  Heather Griffin; Yasmina Soneji; Romy Van Baars; Rupali Arora; David Jenkins; Miekel van de Sandt; Zhonglin Wu; Wim Quint; Robert Jach; Krzysztof Okon; Hubert Huras; Albert Singer; John Doorbar
Journal:  Mod Pathol       Date:  2015-05-08       Impact factor: 7.842

Review 7.  Epidemiologic natural history and clinical management of Human Papillomavirus (HPV) Disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model.

Authors:  Ralph P Insinga; Erik J Dasbach; Elamin H Elbasha
Journal:  BMC Infect Dis       Date:  2009-07-29       Impact factor: 3.090

8.  Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women.

Authors:  Ralph P Insinga; Erik J Dasbach; Elamin H Elbasha; Kai-Li Liaw; Eliav Barr
Journal:  Infect Agent Cancer       Date:  2007-07-12       Impact factor: 2.965

9.  Early impact and performance characteristics of an established anal dysplasia screening program: program evaluation considerations.

Authors:  Christopher Mathews; Joseph Caperna; Edward R Cachay; Bard Cosman
Journal:  Open AIDS J       Date:  2007-11-29

10.  Cost-effectiveness analysis of anal cancer screening in women with cervical neoplasia in British Columbia, Canada.

Authors:  I Cromwell; M Gaudet; S J Peacock; C Aquino-Parsons
Journal:  BMC Health Serv Res       Date:  2016-06-27       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.